enoxacin has been researched along with Chronic Disease in 11 studies
Enoxacin: A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID.
enoxacin : A 1,8-naphthyridine derivative that is 1,4-dihydro-1,8-naphthyridine with an ethyl group at the 1 position, a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a piperazin-1-yl group at the 7 position. An antibacterial, it is used in the treatment of urinary-tract infections and gonorrhoea.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "We selected 198 cases of III A prostatitis with complete treatment and follow-up data from the outpatients, all treated by enoxacin injection for 1 week, followed by oral medication of enoxacin for 2 weeks." | 9.14 | [Enoxacin for type III A prostatitis: a clinical observation]. ( Chen, Z; Chen, ZQ; Deng, RJ; Ye, ZQ; Zhou, XC, 2010) |
| "A total of 43 hospitalized adult patients with acute exacerbations of chronic bronchitis or bronchiectasis due to Gram-negative bacteria were randomized to receive either enoxacin (400 mg bd) or amoxycillin (1,000 mg tid) for 7-12 days." | 9.06 | Enoxacin in acute exacerbations of chronic bronchitis: a comparison with amoxycillin. ( Blogie, M; Carpiaux, JP; Glupczynski, Y; Prigogine, T; Schmerber, JS; Yourassowsky, E, 1988) |
| "The clinical efficacy of enoxacin (ENX) was evaluated in 39 patients having chronic prostatitis." | 7.67 | [The therapeutic effect of enoxacin on chronic prostatitis]. ( Katsumi, T; Murayama, K, 1989) |
| "To examine the diffusion of enoxacin into the prostatic fluid of patients with chronic prostatitis, the serum level and the expressed prostatic secretion (EPS) level of enoxacin were measured." | 7.67 | [The diffusion of enoxacin into the prostatic fluid in the chronic prostatitis patient]. ( Hirabayashi, S; Nakano, Y; Ono, Y; Tanaka, K; Yamada, S, 1988) |
| "Enoxacin was administered at the daily dosage of 400 mg every 12 hours for 10 days starting from the enrollment." | 6.66 | [Enoxacin in the treatment of bacterial prostato-cystitis]. ( Austoni, E; Dal Prà, ML; Mandressi, A; Mantovani, F; Mascheroni, E; Montanari, E; Pisani, E, 1989) |
| "We selected 198 cases of III A prostatitis with complete treatment and follow-up data from the outpatients, all treated by enoxacin injection for 1 week, followed by oral medication of enoxacin for 2 weeks." | 5.14 | [Enoxacin for type III A prostatitis: a clinical observation]. ( Chen, Z; Chen, ZQ; Deng, RJ; Ye, ZQ; Zhou, XC, 2010) |
| "A total of 43 hospitalized adult patients with acute exacerbations of chronic bronchitis or bronchiectasis due to Gram-negative bacteria were randomized to receive either enoxacin (400 mg bd) or amoxycillin (1,000 mg tid) for 7-12 days." | 5.06 | Enoxacin in acute exacerbations of chronic bronchitis: a comparison with amoxycillin. ( Blogie, M; Carpiaux, JP; Glupczynski, Y; Prigogine, T; Schmerber, JS; Yourassowsky, E, 1988) |
| "Enoxacin was effective in 35%; ciprofloxacin (five publications) was used in 82 patients with 67% effectivity in otitis externa and otitis media and 61% effectivity in radical mastoid cavity infection." | 3.76 | The use of fluoroquinolones in chronic otitis suppurativa. ( Claes, J; Pattyn, SR; Valcke, HD; van Caekenberghe, DL; van de Heyning, PH, 1987) |
| "The clinical efficacy of enoxacin (ENX) was evaluated in 39 patients having chronic prostatitis." | 3.67 | [The therapeutic effect of enoxacin on chronic prostatitis]. ( Katsumi, T; Murayama, K, 1989) |
| "To examine the diffusion of enoxacin into the prostatic fluid of patients with chronic prostatitis, the serum level and the expressed prostatic secretion (EPS) level of enoxacin were measured." | 3.67 | [The diffusion of enoxacin into the prostatic fluid in the chronic prostatitis patient]. ( Hirabayashi, S; Nakano, Y; Ono, Y; Tanaka, K; Yamada, S, 1988) |
| "Enoxacin was administered at the daily dosage of 400 mg every 12 hours for 10 days starting from the enrollment." | 2.66 | [Enoxacin in the treatment of bacterial prostato-cystitis]. ( Austoni, E; Dal Prà, ML; Mandressi, A; Mantovani, F; Mascheroni, E; Montanari, E; Pisani, E, 1989) |
| "Enoxacin is a safe and effective alternative to parenteral treatment of lower respiratory tract infections." | 1.27 | Enoxacin in the treatment of lower respiratory tract infections. ( Arnaud, A; Frances, Y; Nourrit, J; Philip-Joet, F, 1988) |
| " AT-2266 was administered in a daily dosage of 600 mg (in 3 divided doses) for 14 days." | 1.27 | [Therapeutic studies on chronic prostatitis--use of AT-2266--Sapporo Clinical Research Group for STD]. ( Gohro, T; Henmi, I; Inoke, T; Kato, S; Kumamoto, Y; Saka, T; Sakai, S; Tabata, S; Tamate, H; Tanda, H, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (90.91) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z | 1 |
| Zhou, XC | 1 |
| Chen, ZQ | 1 |
| Ye, ZQ | 1 |
| Deng, RJ | 1 |
| Jauregui, LE | 1 |
| Hageage, G | 1 |
| Martin, M | 1 |
| Hara, K | 1 |
| Saito, A | 1 |
| Izumikawa, K | 1 |
| Yamaguchi, K | 1 |
| Suzuyama, Y | 1 |
| Shigeno, Y | 1 |
| Watanabe, K | 1 |
| Komori, M | 1 |
| Yamashita, K | 1 |
| Miyazaki, Y | 1 |
| Mantovani, F | 1 |
| Mascheroni, E | 1 |
| Dal Prà, ML | 1 |
| Montanari, E | 1 |
| Mandressi, A | 1 |
| Austoni, E | 1 |
| Pisani, E | 1 |
| Katsumi, T | 1 |
| Murayama, K | 1 |
| Davies, BI | 1 |
| Maesen, FP | 1 |
| Teengs, JP | 1 |
| Baur, C | 1 |
| Prigogine, T | 1 |
| Glupczynski, Y | 1 |
| Carpiaux, JP | 1 |
| Blogie, M | 1 |
| Yourassowsky, E | 1 |
| Schmerber, JS | 1 |
| Tanaka, K | 1 |
| Nakano, Y | 1 |
| Ono, Y | 1 |
| Hirabayashi, S | 1 |
| Yamada, S | 1 |
| Philip-Joet, F | 1 |
| Nourrit, J | 1 |
| Frances, Y | 1 |
| Arnaud, A | 1 |
| van de Heyning, PH | 1 |
| Pattyn, SR | 1 |
| Valcke, HD | 1 |
| van Caekenberghe, DL | 1 |
| Claes, J | 1 |
| Kumamoto, Y | 1 |
| Sakai, S | 1 |
| Tamate, H | 1 |
| Gohro, T | 1 |
| Inoke, T | 1 |
| Tabata, S | 1 |
| Tanda, H | 1 |
| Kato, S | 1 |
| Saka, T | 1 |
| Henmi, I | 1 |
1 review available for enoxacin and Chronic Disease
| Article | Year |
|---|---|
The use of fluoroquinolones in chronic otitis suppurativa.
Topics: Cholesteatoma; Chronic Disease; Ciprofloxacin; Clinical Trials as Topic; Enoxacin; Humans; Mastoidit | 1987 |
5 trials available for enoxacin and Chronic Disease
| Article | Year |
|---|---|
[Enoxacin for type III A prostatitis: a clinical observation].
Topics: Adult; Anti-Infective Agents; Chronic Disease; Enoxacin; Humans; Male; Middle Aged; Prostatitis; Tre | 2010 |
[Comparative clinical study of enoxacin (AT-2266, ENX) and cefaclor (CCL) in chronic respiratory tract infections by a double-blind method].
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteria; Cefaclor; Cephalexin; Chronic Disease; Clinical Trials | 1984 |
[Enoxacin in the treatment of bacterial prostato-cystitis].
Topics: Acute Disease; Adult; Aged; Bacterial Infections; Chronic Disease; Clinical Trials as Topic; Cystiti | 1989 |
Enoxacin in acute exacerbations of chronic bronchitis: a comparison with amoxycillin.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Bacterial Infecti | 1988 |
The use of fluoroquinolones in chronic otitis suppurativa.
Topics: Cholesteatoma; Chronic Disease; Ciprofloxacin; Clinical Trials as Topic; Enoxacin; Humans; Mastoidit | 1987 |
6 other studies available for enoxacin and Chronic Disease
| Article | Year |
|---|---|
Oral enoxacin versus conventional intravenous antimicrobial therapy for chronic osteomyelitis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Chronic Dis | 1989 |
[The therapeutic effect of enoxacin on chronic prostatitis].
Topics: Adult; Chronic Disease; Drug Evaluation; Enoxacin; Humans; Male; Middle Aged; Prostatitis | 1989 |
[New oral quinolone compounds in chronic bronchitis].
Topics: Administration, Oral; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Chronic Disease; Cipr | 1986 |
[The diffusion of enoxacin into the prostatic fluid in the chronic prostatitis patient].
Topics: Adult; Aged; Body Fluids; Chronic Disease; Diffusion; Enoxacin; Humans; Male; Middle Aged; Prostate; | 1988 |
Enoxacin in the treatment of lower respiratory tract infections.
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Bronchiectasis; Bronchitis; Chronic Disease; Drug | 1988 |
[Therapeutic studies on chronic prostatitis--use of AT-2266--Sapporo Clinical Research Group for STD].
Topics: Adult; Aged; Anti-Infective Agents; Chronic Disease; Drug Administration Schedule; Enoxacin; Humans; | 1986 |